Galectin Therapeutics GALT
NASDAQ GALT
$3.18 -0.11 (-3.19%)
As of: Nov 12, 2026 · 1:09 PM EST

Galectin Therapeutics (GALT) Cash from Investing Activities (2009 - 2014)

Updated

Galectin Therapeutics (GALT) posted Cash from Investing Activities of -$400,000 for FY2014.

Analysis

Galectin Therapeutics (GALT) Cash from Investing Activities (2009 - 2014) Analysis & Trends

  • Business Quant data shows GALT's Cash from Investing Activities at $64,000 in FY2012 and -$15,000 in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -8.30 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -2.71 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -10.22 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -1.32 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -1.89 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -649.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -244.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -2.03 Bn
10 Galectin Therapeutics 224.13 Mn 167.48 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 -400,000.00
Dec 31, 2013 -835,000.00
Sep 30, 2013 -835,000.00
Jun 30, 2013 -835,000.00
Mar 31, 2013 -835,000.00
Dec 31, 2012 56,000.00
Sep 30, 2012 907,000.00
Jun 30, 2012 -899,000.00
Mar 31, 2012 -899,000.00
Dec 31, 2011 -5,000.00
Sep 30, 2011 -5,000.00
Jun 30, 2011 879,000.00
Mar 31, 2011 -884,000.00
Mar 31, 2010 -884,000.00
Mar 31, 2009 -884,000.00
API Access

Galectin Therapeutics Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=GALT&period=max&api_key=YOUR_API_KEY